Cargando…
Anti-Scg3 Gene Therapy to Treat Choroidal Neovascularization in Mice
Neovascular age-related macular degeneration (nAMD) with choroidal neovascularization (CNV) is a leading cause of blindness in the elderly in developed countries. The disease is currently treated with anti-angiogenic biologics, including aflibercept, against vascular endothelial growth factor (VEGF)...
Autores principales: | Huang, Chengchi, Ji, Liyang, Kaur, Avinash, Tian, Hong, Waduge, Prabuddha, Webster, Keith A., Li, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377229/ https://www.ncbi.nlm.nih.gov/pubmed/37509549 http://dx.doi.org/10.3390/biomedicines11071910 |
Ejemplares similares
-
Secretogranin III Selectively Promotes Vascular Leakage in the Deep Vascular Plexus of Diabetic Retinopathy
por: Ji, Liyang, et al.
Publicado: (2023) -
Inhibitory effect of anti-Scg3 on corneal neovascularization: a preliminary study
por: Jin, He, et al.
Publicado: (2022) -
Optimal Efficacy and Safety of Humanized Anti-Scg3 Antibody to Alleviate Oxygen-Induced Retinopathy
por: He, Ye, et al.
Publicado: (2021) -
Choroidal neovascular membrane in a treated choroidal hemangioma
por: Nagesha, Chokkahalli K, et al.
Publicado: (2016) -
Choroidal Osteoma and Secondary Choroidal Neovascularization Treated with Ranibizumab
por: Sarıgül Sezenöz, Almila, et al.
Publicado: (2017)